Literature DB >> 31773240

Histone epiproteomic profiling distinguishes oligodendroglioma, IDH-mutant and 1p/19q co-deleted from IDH-mutant astrocytoma and reveals less tri-methylation of H3K27 in oligodendrogliomas.

C Feller1, M Felix2, T Weiss3, C Herold-Mende4, F Zhang5, T Kockmann6, F Sahm2,7, R Aebersold5,8, A von Deimling2,7, D E Reuss9,10.   

Abstract

Entities:  

Year:  2019        PMID: 31773240     DOI: 10.1007/s00401-019-02096-8

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  7 in total

1.  Frequency of false-positive FISH 1p/19q codeletion in adult diffuse astrocytic gliomas.

Authors:  Matthew K Ball; Thomas M Kollmeyer; Corinne E Praska; Michelle L McKenna; Caterina Giannini; Aditya Raghunathan; Mark E Jentoft; Daniel H Lachance; Benjamin R Kipp; Robert B Jenkins; Cristiane M Ida
Journal:  Neurooncol Adv       Date:  2020-08-27

2.  ISL2 modulates angiogenesis through transcriptional regulation of ANGPT2 to promote cell proliferation and malignant transformation in oligodendroglioma.

Authors:  Lin Qi; Zhong-Yong Wang; Xin-Rong Shao; Miao Li; Shu-Na Chen; Xue-Qi Liu; Shi Yan; Bo Zhang; Xu-Dong Zhang; Xin Li; Wenxue Zhao; Ji-An Pan; Bo Zhao; Xing-Ding Zhang
Journal:  Oncogene       Date:  2020-08-04       Impact factor: 9.867

3.  Loss of H3K27 trimethylation is frequent in IDH1-R132H but not in non-canonical IDH1/2 mutated and 1p/19q codeleted oligodendroglioma: a Japanese cohort study.

Authors:  Umma Habiba; Hirokazu Sugino; Roumyana Yordanova; Koki Ise; Zen-Ichi Tanei; Yusuke Ishida; Satoshi Tanikawa; Shunsuke Terasaka; Ken-Ichi Sato; Yuuta Kamoshima; Masahiko Katoh; Motoo Nagane; Junji Shibahara; Masumi Tsuda; Shinya Tanaka
Journal:  Acta Neuropathol Commun       Date:  2021-05-21       Impact factor: 7.578

4.  A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy.

Authors:  Joachim P Steinbach; Patrick N Harter; Oliver Bähr; Eike Steidl; Katharina Filipski; Pia S Zeiner; Marlies Wagner; Emmanouil Fokas; Marie-Therese Forster; Michael W Ronellenfitsch; Iris Divé
Journal:  J Cancer Res Clin Oncol       Date:  2021-02-04       Impact factor: 4.553

5.  Oligosarcomas, IDH-mutant are distinct and aggressive.

Authors:  Christian Hartmann; David E Reuss; Abigail K Suwala; Marius Felix; Dennis Friedel; Damian Stichel; Daniel Schrimpf; Felix Hinz; Ekkehard Hewer; Leonille Schweizer; Hildegard Dohmen; Ute Pohl; Ori Staszewski; Andrey Korshunov; Marco Stein; Thidathip Wongsurawat; Pornsuk Cheunsuacchon; Sith Sathornsumetee; Christian Koelsche; Clinton Turner; Emilie Le Rhun; Angelika Mühlebner; Philippe Schucht; Koray Özduman; Takahiro Ono; Hiroaki Shimizu; Marco Prinz; Till Acker; Christel Herold-Mende; Tobias Kessler; Wolfgang Wick; David Capper; Pieter Wesseling; Felix Sahm; Andreas von Deimling
Journal:  Acta Neuropathol       Date:  2021-12-30       Impact factor: 17.088

6.  H3K27me3 immunostaining is diagnostic and prognostic in diffuse gliomas with oligodendroglial or mixed oligoastrocytic morphology.

Authors:  Aldo Scarpa; Valeria Barresi; Serena Ammendola; Nicolò Caldonazzi; Michele Simbolo; Maria Liliana Piredda; Matteo Brunelli; Pietro Luigi Poliani; Giampietro Pinna; Francesco Sala; Claudio Ghimenton
Journal:  Virchows Arch       Date:  2021-06-24       Impact factor: 4.535

7.  ChromID identifies the protein interactome at chromatin marks.

Authors:  Rodrigo Villaseñor; Ramon Pfaendler; Christina Ambrosi; Stefan Butz; Sara Giuliani; Elana Bryan; Thomas W Sheahan; Annika L Gable; Nina Schmolka; Massimiliano Manzo; Joël Wirz; Christian Feller; Christian von Mering; Ruedi Aebersold; Philipp Voigt; Tuncay Baubec
Journal:  Nat Biotechnol       Date:  2020-03-02       Impact factor: 68.164

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.